Clinical Trials Logo

Clinical Trial Summary

Acute Stanford type A aortic dissection (TAAD) is a life-threatening condition. Surgery is usually performed as a salvage procedure and is associated with significant postoperative early mortality and morbidity. Understanding the patient's conditions and treatment strategies which are associated with these adverse events is essential for an appropriate management of acute TAAD.


Clinical Trial Description

Twenty centers from eight European centers of cardiac surgery have collaborated to create a multicentre observational registry (ERTAAD), which will enroll consecutive patients who underwent surgery for acute TAAD from January 2005 to March 2021. The investigators will compare patient's comorbidities, condition at referral, surgical strategies and perioperative treatments in patients with and without early and late adverse events. The primary clinical outcome will be in-hospital mortality, late mortality and reoperations on the aorta. Secondary outcomes will be stroke, acute kidney injury, surgical site infection, reoperation for bleeding, transfusion of blood products and length of stay in the intensive care unit. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04831073
Study type Observational
Source Helsinki University Central Hospital
Contact
Status Active, not recruiting
Phase
Start date February 28, 2023
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06199401 - Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery N/A
Active, not recruiting NCT03369977 - BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients N/A
Completed NCT05751200 - Safety and Efficacy of Aortic Root Reinforcement Combined With Vascular Grafts Eversion and built-in Procedure (XJ-procedure) in Patients With Acute Type A Aortic Dissection (ADVANCED-XJ )
Completed NCT04711889 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II N/A
Recruiting NCT03607786 - Antegrade Cerebral Perfusion and Retrograde Inferior Vena Caval Perfusion for Total Aortic Arch Replacement N/A
Completed NCT06415630 - Prediction Models for Postoperative Reintubation in Patients With Acute Aortic Dissection
Enrolling by invitation NCT05927090 - Outcomes of Type A Aortic Dissection Repair
Completed NCT05346497 - Surgical Management of the Aortic Root and Long-term Outcomes For Acute Type A Aortic Dissection
Recruiting NCT06434987 - Impact of RIVP on GI Function in Patients Undergoing Surgical Repair for ATAAD
Completed NCT02164201 - Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery N/A
Recruiting NCT04032366 - iNO as Salvage Treatment of Hypoxemia After TAAD Surgery